Filter News
Area of Research
- (-) Computer Science (5)
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (43)
- Clean Energy (31)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (4)
- Isotopes (23)
- Materials (43)
- Materials for Computing (9)
- National Security (31)
- Neutron Science (24)
- Quantum information Science (4)
- Sensors and Controls (1)
- Supercomputing (95)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (1)
- (-) Computer Science (6)
- (-) Isotopes (4)
- (-) Machine Learning (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Bioenergy (1)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (1)
- Fusion (7)
- Materials Science (4)
- Molten Salt (1)
- Neutron Science (2)
- Nuclear Energy (23)
- Physics (2)
- Quantum Science (2)
- Space Exploration (3)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.